{"transactions":[{"id":740100,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T21:05:14.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 11, 2027, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74000,"derivative":{"exercise_price":2.24,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001816465-26-000002","document":"form4-06122026_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000181646526000002/form4-06122026_090611.xml","form_type":"4"}},{"id":740064,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:05:06.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":25800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 11, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":25800,"derivative":{"exercise_price":17.1,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":25800},"source":{"system":"sec-edgar","filing":"0001193125-26-269349","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000119312526269349/ownership.xml","form_type":"4"}},{"id":1109907,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:26:22.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 12, 2026, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":0.6,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-25-011788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299325011788/form4.xml","form_type":"4"}},{"id":1109866,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T16:05:08.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":30700,"derivative":{"exercise_price":4.91,"expiration_date":"2035-06-13","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000950170-25-086702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000095017025086702/ownership.xml","form_type":"4"}},{"id":1472176,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T20:48:57.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 20, 2025, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":2.69,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-24-012900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299324012900/form4.xml","form_type":"4"}},{"id":1480837,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T16:30:06.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":22100,"derivative":{"exercise_price":4.16,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0000950170-24-073059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000095017024073059/ownership.xml","form_type":"4"}},{"id":1659121,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T19:11:29.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":250000,"derivative":{"exercise_price":11.69,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001725160-24-000026","document":"wk-form4_1707178279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516024000026/wk-form4_1707178279.xml","form_type":"4"}},{"id":1659120,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T19:11:29.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20655,"price":11.69,"value":241456.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares automatically withheld to satisfy tax obligations upon the vesting of restricted stock units previously granted to the Reporting Person."}],"balance_after":484145,"source":{"system":"sec-edgar","filing":"0001725160-24-000026","document":"wk-form4_1707178279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516024000026/wk-form4_1707178279.xml","form_type":"4"}},{"id":1659119,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-05T19:11:29.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":504800,"source":{"system":"sec-edgar","filing":"0001725160-24-000026","document":"wk-form4_1707178279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516024000026/wk-form4_1707178279.xml","form_type":"4"}},{"id":1744138,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-13T17:24:08.000Z","date":"2023-11-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":10.2896,"value":51448.0,"ownership":{"direct":true},"balance_after":254800,"source":{"system":"sec-edgar","filing":"0001725160-23-000200","document":"wk-form4_1699914229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516023000200/wk-form4_1699914229.xml","form_type":"4"}},{"id":1842076,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T20:20:10.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 27, 2024, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":44000,"derivative":{"exercise_price":3.19,"expiration_date":"2024-06-27","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001062993-23-014168","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299323014168/form4.xml","form_type":"4"}},{"id":1854562,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T16:26:54.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":20500,"derivative":{"exercise_price":6.59,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001209191-23-037348","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000120919123037348/doc4.xml","form_type":"4"}},{"id":2038646,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T19:08:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":355200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":355200,"derivative":{"exercise_price":23.65,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":355200},"source":{"system":"sec-edgar","filing":"0001725160-23-000018","document":"wf-form4_167529647568841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516023000018/wf-form4_167529647568841.xml","form_type":"4"}},{"id":2038645,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-01T19:08:10.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":244800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":249800,"source":{"system":"sec-edgar","filing":"0001725160-23-000018","document":"wf-form4_167529647568841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516023000018/wf-form4_167529647568841.xml","form_type":"4"}},{"id":2230130,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T16:30:09.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2023 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":15000,"derivative":{"exercise_price":7.66,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-037421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000120919122037421/doc4.xml","form_type":"4"}},{"id":2236316,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:23:17.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":19872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 9, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":19872,"derivative":{"exercise_price":8.56,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":19872},"source":{"system":"sec-edgar","filing":"0001062993-22-014656","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000106299322014656/form4.xml","form_type":"4"}},{"id":2262031,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T16:27:31.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":427202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the shares on the earlier of (a) FDA approval of a Zentalis product or (b) a Change in Control (as defined in the Issuer's 2020 Incentive Award Plan)."}],"balance_after":427202,"derivative":{"exercise_price":24.41,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":427202},"source":{"system":"sec-edgar","filing":"0001725160-22-000100","document":"wf-form4_165307841185112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516022000100/wf-form4_165307841185112.xml","form_type":"4"}},{"id":2262030,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T16:27:31.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":1708809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the shares on May 16, 2023 and vests in equal monthly installments thereafter until May 16, 2026."}],"balance_after":1708809,"derivative":{"exercise_price":24.41,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":1708809},"source":{"system":"sec-edgar","filing":"0001725160-22-000100","document":"wf-form4_165307841185112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516022000100/wf-form4_165307841185112.xml","form_type":"4"}},{"id":2444382,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T17:49:28.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant on July 1, 2020."}],"balance_after":38000,"derivative":{"exercise_price":47.8,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001725160-22-000005","document":"wf-form4_164142295564507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516022000005/wf-form4_164142295564507.xml","form_type":"4"}},{"id":2444381,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:49:28.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1000,"price":83.74,"value":83740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001725160-22-000005","document":"wf-form4_164142295564507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516022000005/wf-form4_164142295564507.xml","form_type":"4"}},{"id":2444380,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T17:49:28.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":1000,"price":47.8,"value":47800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001725160-22-000005","document":"wf-form4_164142295564507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516022000005/wf-form4_164142295564507.xml","form_type":"4"}},{"id":2489004,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-02T19:16:27.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant, July 1, 2020."}],"balance_after":39000,"derivative":{"exercise_price":47.8,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001725160-21-000231","document":"wf-form4_163849056773691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000231/wf-form4_163849056773691.xml","form_type":"4"}},{"id":2489003,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T19:16:27.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":1000,"price":81.84,"value":81840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001725160-21-000231","document":"wf-form4_163849056773691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000231/wf-form4_163849056773691.xml","form_type":"4"}},{"id":2489002,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T19:16:27.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":1000,"price":47.8,"value":47800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001725160-21-000231","document":"wf-form4_163849056773691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000231/wf-form4_163849056773691.xml","form_type":"4"}},{"id":2529180,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-02T19:24:22.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant, July 1, 2020."}],"balance_after":40000,"derivative":{"exercise_price":47.8,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001725160-21-000210","document":"wf-form4_163589544514963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000210/wf-form4_163589544514963.xml","form_type":"4"}},{"id":2529179,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T19:24:22.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":1000,"price":80.46,"value":80460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001725160-21-000210","document":"wf-form4_163589544514963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000210/wf-form4_163589544514963.xml","form_type":"4"}},{"id":2529178,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T19:24:22.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":1000,"price":47.8,"value":47800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001725160-21-000210","document":"wf-form4_163589544514963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000210/wf-form4_163589544514963.xml","form_type":"4"}},{"id":2533726,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-27T20:13:31.000Z","date":"2021-10-25","kind":"exercise","acquired":false,"shares":1000,"price":47.8,"value":47800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant, July 1, 2020."}],"balance_after":41000,"derivative":{"exercise_price":47.8,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001725160-21-000207","document":"wf-form4_163537999719527.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000207/wf-form4_163537999719527.xml","form_type":"4"}},{"id":2533725,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-27T20:13:31.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":1000,"price":77.59,"value":77590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001725160-21-000207","document":"wf-form4_163537999719527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000207/wf-form4_163537999719527.xml","form_type":"4"}},{"id":2533724,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-27T20:13:31.000Z","date":"2021-10-25","kind":"exercise","acquired":true,"shares":1000,"price":47.8,"value":47800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock option exercise and sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2021."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001725160-21-000207","document":"wf-form4_163537999719527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000207/wf-form4_163537999719527.xml","form_type":"4"}},{"id":2654997,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:00:57.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":47132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on June 28, 2021."}],"balance_after":47132,"derivative":{"exercise_price":19,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":47132},"source":{"system":"sec-edgar","filing":"0000899243-21-025980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000089924321025980/doc4.xml","form_type":"4"}},{"id":2654996,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-25T17:00:57.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":7081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on April 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 17, 2021, the Issuer completed a one-for-3.5305 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":7081,"derivative":{"exercise_price":6.14,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":7081},"source":{"system":"sec-edgar","filing":"0000899243-21-025980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000089924321025980/doc4.xml","form_type":"4"}},{"id":2661499,"issuer":{"id":5739,"kind":"organization","name":"Century Therapeutics, Inc.","symbol":"IPSC"},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-21T20:34:27.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":19872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":19872,"derivative":{"exercise_price":20,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":19872},"source":{"system":"sec-edgar","filing":"0001192482-21-000562","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850119/000119248221000562/edgar.xml","form_type":"4"}},{"id":2677871,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T17:27:36.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and become exercisable in substantially equal monthly installments over the twelve (12) months following the date of grant, subject to the Reporting Person's continued service on the Board of Directors through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":52.25,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001725160-21-000143","document":"wf-form4_162318762722493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000143/wf-form4_162318762722493.xml","form_type":"4"}},{"id":2677870,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T17:27:36.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 4, 2022 or (b) the next occurring annual meeting of the Company's stockholders, subject to the Reporting Person's continued service on the Board of Directors through such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001725160-21-000143","document":"wf-form4_162318762722493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000172516021000143/wf-form4_162318762722493.xml","form_type":"4"}},{"id":3095423,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":38783,"kind":"person","name":"Blackwell Kimberly","position":1,"cik":"0001816465","reported_name":"Blackwell Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-01T20:28:25.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant."}],"balance_after":42000,"derivative":{"exercise_price":47.8,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0000899243-20-018186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816465/000089924320018186/doc4.xml","form_type":"4"}}]}